Formed last year after Nestle acquired full ownership of the Galderma brand from cosmetics maker L’Oreal, the subsidiary has been focusing on market expansion and opportunity.
“Our goal is to grow the number of people the company serves to over a billion within 10 years, by offering skin health solutions that protect, maintain, nourish and enhance skin health and, when skin health is compromised, treat, correct and restore the skin to its healthy state,” says Humberto C. Antunes, CEO of Nestlé Skin Health S.A. and Chairman of the Board of Galderma Pharma S.A.
“We are focused on enhancing the quality of life by delivering science-based solutions for the health of skin, hair and nails.”
Consumer business created
The Lausanne-based company states that Galderma will continue to partner with healthcare professionals to provide innovative medical solutions in dermatology, while a Consumer Skin Health business has been created to focus on meeting skin health needs in the broader market place worldwide.
In the Consumer Skin Health business Albert Draaijer, formerly Senior Vice President Markets & Franchises at Galderma, has been appointed Senior Vice President, and has ambitions of reaching more consumers.
“With this new structure, our existing brands, such as Cetaphil and Daylong, we will find new channels and reach even more consumers, while allowing us to develop new science-based solutions for people around the world” he says.
Elsewhere in Nestlé’s Skin Health business, Janusz Czernielewski, formerly Vice President, Medical Affairs at Galderma, is appointed Vice President, Medical Affairs; Cécile Dussart, formerly Vice President, Manufacturing and Technical Operations at Galderma, is appointed Vice President, Manufacturing and Technical Operations; and Alain Jacot, formerly Vice President, Scientific Division at Galderma, is appointed Vice President, Scientific Division of Nestlé Skin Health.
There are also new roles for Alain Kirsch in Human Resources, Torsten Koster in Finance, Christian Matton in Corporate General Counsel, and Peter Nicholson who is appointed Vice President, Business Development & Strategy of Nestlé Skin Health.
Stuart Raetzman is also appointed CEO of Galderma Pharma S.A. which includes Prescription, Self-medication and Aesthetic & Corrective medical solutions.
“Our unique focus on the skin clearly positions us as leaders in the dermatology market and this is set to continue” he adds.